ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1SCImago #31,883Subscription

European Review for Medical and Pharmacological Sciences

Abbreviation (ISO):EUR. REV. MED. PHARMACOL. SCI
•
Identifier (ISSN):1128-3602(Print)/2284-0729(Online)
•
Publisher:Verduci Editore
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend (2018–2023)

Clarivate IF trend for European Review for Medical and Pharmacological Sciences

WoS Q1
12452.3920182.7220193.0220203.5120213.7820223.32023
Annual Impact Factor Metric
Current (2023):3.3
Scopus SJR & Rank
N/A
#31,883

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
103

103 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
843articles/year
0% Gold OA•86.94% Original Research

Aims & Scope

European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicineGeneticsChemistryBiochemistryPathologySurgeryEndocrinologyImmunologyPsychologyCancer ResearchOncology & Cancer ResearchPsychiatryRadiologyCell Biology
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

18 year
2023Latest
IF3.3
Articles / Year—
Total Citations—
2022
IF3.784
Articles / Year—
Total Citations—
2021
IF3.507
Articles / Year—
Total Citations—
2020
IF3.024
Articles / Year—
Total Citations—
2019
IF2.721
Articles / Year—
Total Citations—

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #31,883SCImago Profile
Scopus Coverage:1979-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)
—

Weighted prestige citation metric per document indexed in the Scopus database.

Normalized Data
Citations / Doc (2 years)
1.84

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,052 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5,472
3-Year Documents2,918
Citable Documents2,875

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate36.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)—
Pharmacology (medical)—
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
In warning list
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

European Review for Medical and Pharmacological Sciences (abbr: EUR. REV. MED. PHARMACOL. SCI, ISSN: 1128-3602) is a peer-reviewed international scholarly journal in the field of Medicine, published by Verduci Editore in Italy since 1997. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, an H-index of 103.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 843 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $3,052 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
Verduci Editore
Publication Language
English
Frequency
Bimonthly
Founding Year
1997
Indexing & Databases
SCIEScopusPubMed
Editorial Address
VERDUCI PUBLISHER, VIA GREGORIO VII, ROME, ITALY, 186-00165

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2d6671c1-3923-4edd-a7c3-ea7e61db6c8b
Database Updated: 2026-09-28